Medical News

RSS

Transcept Pharmaceuticals' agreement with Purdue Pharmaceutical Products may lead to staff reduction

Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced plans to reduce operating expenses by eliminating certain staff positions following its recently announced License and Collaboration Agreement with Purdue Pharmaceutical Products to commercialize Intermezzo((R) )(zolpidem tartrate sublingual tablet) in the United States.

19 Aug 2009

Watson Pharmaceuticals offers unsecured notes up to $850 million

Watson Pharmaceuticals, Inc. (NYSE: WPI), a specialty pharmaceutical company, today announced that it is offering up to $850 million aggregate principal amount of five and ten year senior unsecured notes in a registered public offering.

19 Aug 2009

New production technology to develop vaccine for norovirus

Scientists have used a new vaccine production technology to develop a vaccine for norovirus, a dreaded cause of diarrhea and vomiting that may be the second most common viral infection in the United States after the flu. Sometimes called the "cruise ship virus," this microbe can spread like wildfire through passenger liners, schools, offices and military bases.

19 Aug 2009

The iPosture now available in UK

The iPosture, a posture improvement device developed by Memphis-based neurologist Moacir Schnapp, M.D., is now available for purchase in the United Kingdom via iPosture Direct.

19 Aug 2009

Efforts to create treatment guidelines are often complicated

The development of treatment guidelines for illnesses such as diabetes is a complicated process.

19 Aug 2009

Indoor Tanning Association denounces Suffolk Bill banning teens under the age of 18 from using a sun-bed

Today the Indoor Tanning Association (ITA) denounced Introduced Resolution 1714, which would ban Suffolk teens under the age of 18 from using a sun-bed.

19 Aug 2009

Fatigue during radiotherapy for breast or prostate cancer may be caused by inflammation

Patients who experience fatigue during radiotherapy for breast or prostate cancer may be reacting to activation of the proinflammatory cytokine network, a known inflammatory pathway, according to a report in Clinical Cancer Research, a journal of the American Association for Cancer Research.

19 Aug 2009

Discovery of key factor that stimulates brain cancer cells to spread

Researchers funded by the National Institutes of Health have found that the activity of a protein in brain cells helps stimulate the spread of an aggressive brain cancer called glioblastoma multiforme (GBM). In a move toward therapy, the researchers showed that a small designer protein can block this activity and reduce the spreading of GBM cells grown in the laboratory.

19 Aug 2009

TBI's new Ocular Services Division to replace its Tissue Distribution and Information Center

TBI/Tissue Banks International, Inc. today announced it has developed an Ocular Services Division to replace the Tissue Distribution and Information Center at the organization.

19 Aug 2009

Low-dose estrogen effective for metastatic breast cancer

When estrogen-lowering drugs no longer control metastatic breast cancer, the opposite strategy might work. Raising estrogen levels benefited 30 percent of women whose metastatic breast cancer no longer responded to standard anti-estrogen treatment, according to research conducted at Washington University School of Medicine in St. Louis and collaborating institutions.

19 Aug 2009

Massachusetts could prove model to cut costs

CNNMoney reports that Massachusetts could prove to be a model for how to grapple with high health care costs as its own soaring costs threaten national efforts at reform.

19 Aug 2009

Xceleron to acquire an Accelerator Mass Spectrometry instrument under agreement with GlaxoSmithKline

XCELERON, a leader in the field of ultra-sensitive bioanalytical studies supporting clinical research, today announced that it has signed a second Master Service Agreement with GlaxoSmithKline. Under the terms of this agreement, Xceleron will provide analytical support to GlaxoSmithKline and its affiliated research organizations. As part of the deal, Xceleron will increase capacity through the acquisition of an Accelerator Mass Spectrometry (AMS) instrument.

19 Aug 2009

e-infrastructure to tackle diseases

Disease knows no borders and now researchers in Europe and the Mediterranean shoreline are using electronic infrastructures (e-Infrastructures) to coordinate and cooperate internationally.

19 Aug 2009

New study suggests financial situation of U.S. hospitals improving

The median profit margin of U.S. hospitals increased from 0.17 percent in the third quarter of 2008 to 3.1 percent in the first quarter of 2009, according to an analysis of hospital finances published today by Thomson Reuters.

19 Aug 2009

Custom-tailored anti-cancer drugs

Cancer remains a deadly threat despite the best efforts of science. New hopes were raised a few years ago with the discovery that the uncontrolled growth of cancer cells could be thwarted by blocking the action of proteasomes. Biochemists at the Technische Universitaet Muenchen (TUM) have illuminated a reaction pathway that does just that, in collaboration with researchers from Nereus Pharmaceuticals, based in San Diego, California. In the current issue of the Journal of Medicinal Chemistry, they report insights that could potentially lead to the development of custom-tailored anti-cancer drugs.

19 Aug 2009

Candela Corporation reports total revenues of $116.6 million for full-year

Candela Corporation today reported that revenues for the quarter ended June 27, 2009 were $31.4 million. Income from continuing operations, including non-cash expenses of $1.5 million, was $380,000 or $0.02 per share on a fully-diluted basis.

19 Aug 2009

Texas Public Policy Foundation says health plans would cause more harm than good

The health care reform plans pending in the U.S. Congress would cause more harm than good, according to a study released today by the Texas Public Policy Foundation.

19 Aug 2009

Medical fraud creates unknown amount of waste

Lawmakers seek a reduction in the amount of money lost each year to medical fraud. Meanwhile, two Miami doctors are convicted of Medicare fraud.

19 Aug 2009

Looking to September, lawmakers focus on health reform messages, measures

House Republicans are preparing for September and planning to depict Democratic attempts to reform the health care system as "potentially ruinous to small businesses," CQ Politics reports.

19 Aug 2009

Results of Phase IIb dose range finding of oglemilast in chronic obstructive pulmonary disease announced

Forest Laboratories, Inc. (NYSE: FRX) and Glenmark Pharmaceuticals S.A. (Switzerland), a wholly owned subsidiary of Glenmark Pharmaceuticals India (GPL) today announced top-line results from a Phase IIb dose range-finding study of oglemilast in patients with Chronic Obstructive Pulmonary Disease (COPD). Once-daily treatment with oglemilast did not show a statistically meaningful increase from baseline compared to placebo in the primary endpoint trough FEV1, a measure of pulmonary function that is decreased in patients with COPD. Oglemilast was well tolerated at all doses studied.

19 Aug 2009

Medical News

Transcept Pharmaceuticals' agreement with Purdue Pharmaceutical Products may lead to staff reduction

Watson Pharmaceuticals offers unsecured notes up to $850 million

New production technology to develop vaccine for norovirus

The iPosture now available in UK

Efforts to create treatment guidelines are often complicated

Indoor Tanning Association denounces Suffolk Bill banning teens under the age of 18 from using a sun-bed

Fatigue during radiotherapy for breast or prostate cancer may be caused by inflammation

Discovery of key factor that stimulates brain cancer cells to spread

TBI's new Ocular Services Division to replace its Tissue Distribution and Information Center

Low-dose estrogen effective for metastatic breast cancer

Massachusetts could prove model to cut costs

Xceleron to acquire an Accelerator Mass Spectrometry instrument under agreement with GlaxoSmithKline

e-infrastructure to tackle diseases

New study suggests financial situation of U.S. hospitals improving

Custom-tailored anti-cancer drugs

Candela Corporation reports total revenues of $116.6 million for full-year

Texas Public Policy Foundation says health plans would cause more harm than good

Medical fraud creates unknown amount of waste

Looking to September, lawmakers focus on health reform messages, measures

Results of Phase IIb dose range finding of oglemilast in chronic obstructive pulmonary disease announced

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Latest News